WO2023078479A1 - Complément alimentaire - Google Patents
Complément alimentaire Download PDFInfo
- Publication number
- WO2023078479A1 WO2023078479A1 PCT/CZ2022/000043 CZ2022000043W WO2023078479A1 WO 2023078479 A1 WO2023078479 A1 WO 2023078479A1 CZ 2022000043 W CZ2022000043 W CZ 2022000043W WO 2023078479 A1 WO2023078479 A1 WO 2023078479A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- added
- ginger
- food supplement
- food
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 46
- 239000011630 iodine Substances 0.000 claims abstract description 38
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 38
- 239000000203 mixture Substances 0.000 claims abstract description 36
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 34
- 229920002472 Starch Polymers 0.000 claims abstract description 22
- 239000008107 starch Substances 0.000 claims abstract description 22
- 235000019698 starch Nutrition 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 19
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 19
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 19
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 18
- 241000234314 Zingiber Species 0.000 claims abstract description 17
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 17
- 235000008397 ginger Nutrition 0.000 claims abstract description 17
- 239000008103 glucose Substances 0.000 claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 claims abstract description 14
- 229930091371 Fructose Natural products 0.000 claims abstract description 8
- 239000005715 Fructose Substances 0.000 claims abstract description 8
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 8
- 230000036039 immunity Effects 0.000 claims abstract description 8
- 238000005728 strengthening Methods 0.000 claims abstract description 4
- 238000009835 boiling Methods 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 9
- 229940002508 ginger extract Drugs 0.000 claims description 8
- 235000020708 ginger extract Nutrition 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 3
- 239000008240 homogeneous mixture Substances 0.000 claims 2
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229930182490 saponin Natural products 0.000 description 5
- 150000007949 saponins Chemical class 0.000 description 5
- 235000017709 saponins Nutrition 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 235000012206 bottled water Nutrition 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- -1 iodine ions Chemical class 0.000 description 4
- 102000001049 Amyloid Human genes 0.000 description 3
- 108010094108 Amyloid Proteins 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 235000004280 healthy diet Nutrition 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229930004725 sesquiterpene Natural products 0.000 description 2
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020961 Hypocholesterolaemia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010021024 Hypolipidaemia Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002927 anti-mitotic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Definitions
- iodine-containing medical products that are either used as a safe external disinfection agent for the human body (Lugol’s solution, lodiuoh Iodoform, povidone-iodines), or that can be used for ingestion, or in compositions (i.m., i.v. application) to treat thyroid gland diseases (potassium iodide, iodine, Renessans etc.).
- the object of the present invention is a food supplement comprising a composition of a saponin and an amyloid substance, free iodine ions being bound to the obtained composition to produce a sesquiterpenoid-iodide, which improves immunity and practically reduces the toxic influence of free iodine ions to a minimum.
- the principle of the food supplement according to the invention is that the composition comprises from 14.5 to 15.5 g of an amyloid substance, the amyloid substance being food-grade starch, 10.0 to 12,0 g of a saponin, the used saponin being fresh ginger, and 19.6 to 20.0 g of a 5% solution of iodine in ethanol.
- the sesquiterpenes comprised in the ginger extract increase their efficiency (synergic effect).
- Other excipients are food-grade glucose in the amount of 25.0 to 35.0 g and sugar in a quantity of 75.0 to 110.0 g.
- the sugar and glucose mixture may be replaced with fructose in a quantity of 90.0 to 110.0 g. So far. prior-art products have proved that they carry antimicrobial, antiviral and antibacterial effects that were used to treat cholera, dysentery, chlamydia as well as to treat tonsillitis and other diseases with severe symptoms.
- the present invention provides a complex compound with an absolutely precise iodine dose where iodine is in. a biologically active and non-toxic form.
- iodine is used in the J + valency unlike e.g. the use of Lugol's solution, which comprises iodine (I 2 ) and potassium iodide (KI) dissolved in distilled water. Potassium iodide makes dissolution of iodine in water possible, producing I 3 - ions.
- the solution is also an oxidation antiseptic agent, but is inconvenient in that it may cause scars or temporary discoloration of skin. It is not intended for digestion, because iodine in the solution is in the valency and comprises toxic elementary iodine.
- the inventive food supplement comprises compounds of polysaccharides and iodine.
- iodine is present in the J + valency, which is a safer and more considerate iodine complex intended for internal use.
- Blue-coloured iodine in the J + valency is the basic trace element for living organisms. It is this form of iodine that can be found and accumulated in tissues and organs of higher animals and humans.
- Compounds of iodine in the J + valency starch complex of iodine
- the novelty of the present invention consists in the combination of saponins with amyloid structures that have the ability to bind free iodine ions, producing sesquiterpenoid-iodides that improve the support of immunity and also reduce the toxic influence of free iodine ions to a minimum. For this reason, we are submitting an invention relating to a new food supplement that is very efficient and influences immunity as an antibacterial, antiviral product for the human body.
- Fresh ginger which comprises saponins, has positive effects on the alimentary tract proved by many clinical studies. Its active constituents positively stimulate digestion and absorption. Brown rat experiments have confirmed that flesh ginger influences hypoglycaemia, hypocholesterolemia (low cholesterol content in blood) and hypolipidemia and that it might also be used to treat diabetic complications.
- sugar refers to the disaccharide sucrose consisting of D-glucose and D-fructose.
- D-glucose is that it is necessary for the function of the human body; it is the essential and fastest energy source for all body tissues.
- glucose is the only source of energy, which they cannot do without. These tissues consume about 150 g of glucose during 24 hours. Besides, glucose serves as a detoxicant during serious illnesses.
- Lemons contain a high quantity of ascorbic acid and citric acid (3.5-8.0 g/100 g), they have approximately 87 % of water. Therefore, they are used in the natural form in a number of foods; it is especially their juice that is used. They further comprise bioflavonoids, pectin, aromatic essences, provitamin A, vitamin B, about 3 % of saccharides. It is also a source of calcium, potassium, phosphorus, magnesium, iron, zinc and others.
- lemon juice is also advantageous within the present invention for pH adjustment of the entire composition.
- the production method of the food supplement consists in a fresh sliced/diced ginger rhizome being subjected to extraction for 10-15 minutes in 4/5 parts of boiling water of the total volume of water designed for the production, the obtained extract, being separated by decanting, filtering. Subsequently, a mixture with 1/5 parts of the total water volume (t° ⁇ 40 °C) of starch, sugar and glucose or only starch, blended into a homogeneous condition, is added to the boiling ginger extract. The boiled mixture is left to stand for a certain time (at least 20 minutes) to let. the starch gelatinize. Lemon juice is added to the swollen suspension under stirring, and then a iodine solution in ethanol, in the temperature range of approx. 30 - 80 °C.
- fructose In the case of producing a product with fructose, suitable e.g. for diabetics, sugar and glucose are not used. Fructose is only added to the final food supplement at the end of the production.
- the novelty of the production method consists in the lemon juice and Iodine solution in ethanol being added to the above-mentioned composition at an elevated temperature (at 30 - 80 °C). Since normally, a iodine solution in ethanol is added at. the room temperature.
- Example 1 A production method of a food supplement in the gel solution form, comprising: starch - 15.0 g
- the food supplement was produced in the following way: 10.0 g of fresh sliced/diced ginger is extracted in 720.0 g of boiling water and the obtained extract is separated by decanting, filtering.
- the boiled mixture is left to stand for at least 20 min to let the starch gelatinize.
- 30.0 g of natural lemon juice is added to the swollen suspension at 30 - 80 °C, and then 19.8 g of a 5% iodine solution in ethanol at 30 - 80 °C.
- the final product is in the form of a gel solution.
- Example 2 A production method of a food supplement in the gel solution form, comprising:
- the boiled mixture is left to stand for at least. 20 min to let the starch gelatinize.
- 25.0 g of natural lemon juice is added to the swollen suspension at 30 - 80 °C, and then 20.0 g of a 5% iodine solution in ethanol at 30 ⁇ 80 °C.
- the final product is in the form of a gel solution.
- Example 3 A production method of a food supplement In the gel solution form, comprising: starch - 15.0 g 5% iodine solution in ethanol - 19.6 g fresh ginger - 10.0 g, and a mixture comprising natural lemon juice - 32.5 g sugar - 110.0 g glucose - 32.0 g and 950 g of potable water.
- the following was used for the production of the food supplement: 10.0 g of fresh sliced/diced ginger, which is extracted in 760.0 g of boiling water, and the obtained extract is separated by decanting, filtering.
- the boiled mixture is left to stand for at least 20 min to lei the starch gelatinize.
- 32.5 g of natural lemon juice is added to the swollen suspension at 30 - 80 °C, and then 19.6 g of a 5% iodine solution in ethanol at 30 - 80 °C.
- the final food supplement was produced in the form of a gel solution.
- Example 4 A production method of a food supplement in the gel solution, form, comprising: starch - 14.5 g
- the food supplement was produced in a similar way (see above), 12.0 g of fresh sliced/diced ginger, which is extracted in 720 g of boiling water, and the obtained extract is separated by decanting, filtering.
- the boiled mixture is left to stand for at least 60 min to let the starch gelatinize. .35.0 g of natural lemon juice is added to the swollen suspension at 30 - 80 °C, and then 19.6 g of a 5% iodine solution in ethanol at 30 - 80 °C. Finally, 110.0 g of fructose is added at. a temperature lower than 60 °C. I'he final product is in the form of a gel solution.
- a specialized facility subsequently proved the effect of all the analysed samples of the food supplement produced according to the Embodiment Examples 1 to 4 against the bacteria Escherichia coli, which may e.g. cause infection of the urinary tract or intestinal complications.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP22809325.8A EP4426135A1 (fr) | 2021-11-02 | 2022-11-01 | Complément alimentaire |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZPV2021-505 | 2021-11-02 | ||
CZ2021-505A CZ2021505A3 (cs) | 2021-11-02 | 2021-11-02 | Potravinový doplněk |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023078479A1 true WO2023078479A1 (fr) | 2023-05-11 |
Family
ID=84272355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CZ2022/000043 WO2023078479A1 (fr) | 2021-11-02 | 2022-11-01 | Complément alimentaire |
Country Status (2)
Country | Link |
---|---|
CZ (1) | CZ2021505A3 (fr) |
WO (1) | WO2023078479A1 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020136802A1 (en) * | 2000-09-29 | 2002-09-26 | The Procter & Gamble Co. | Beverage compositions comprising arabinogalactan and defined minerals |
US20060024385A1 (en) * | 2004-07-27 | 2006-02-02 | Pedersen Mark A | Metabolic capacity enhancing compositions and methods for use in a mammal |
WO2016069580A1 (fr) * | 2014-10-27 | 2016-05-06 | VitaThinQ, Inc. | Compléments nutritionnels |
US20210220422A1 (en) * | 2020-01-20 | 2021-07-22 | Jonathan Parker | Dietary supplement compositions and methods |
US20210228483A1 (en) * | 2018-06-11 | 2021-07-29 | Seattle Gummy Company | Low glycemic gummy composition and methods of making and using thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2189830C1 (ru) * | 2001-05-21 | 2002-09-27 | Общество с ограниченной ответственностью Фирма "ЭЙКОСЪ" | Биологически активная добавка "лактогон" |
US20210038664A1 (en) * | 2018-02-09 | 2021-02-11 | Atp Institute Pty Ltd | Formulation and method of use |
US11701335B2 (en) * | 2018-08-31 | 2023-07-18 | Apr Applied Pharma Research S.A. | Methods of normalizing amino acid metabolism |
-
2021
- 2021-11-02 CZ CZ2021-505A patent/CZ2021505A3/cs unknown
-
2022
- 2022-11-01 WO PCT/CZ2022/000043 patent/WO2023078479A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020136802A1 (en) * | 2000-09-29 | 2002-09-26 | The Procter & Gamble Co. | Beverage compositions comprising arabinogalactan and defined minerals |
US20060024385A1 (en) * | 2004-07-27 | 2006-02-02 | Pedersen Mark A | Metabolic capacity enhancing compositions and methods for use in a mammal |
WO2016069580A1 (fr) * | 2014-10-27 | 2016-05-06 | VitaThinQ, Inc. | Compléments nutritionnels |
US20210228483A1 (en) * | 2018-06-11 | 2021-07-29 | Seattle Gummy Company | Low glycemic gummy composition and methods of making and using thereof |
US20210220422A1 (en) * | 2020-01-20 | 2021-07-22 | Jonathan Parker | Dietary supplement compositions and methods |
Also Published As
Publication number | Publication date |
---|---|
CZ309544B6 (cs) | 2023-03-29 |
CZ2021505A3 (cs) | 2023-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Musa et al. | Chemistry, biological, and pharmacological properties of gum Arabic | |
Fahmy et al. | Pomegranate juice as a functional food: A comprehensive review of its polyphenols, therapeutic merits, and recent patents | |
Zhu et al. | Structural properties, bioactivities, and applications of polysaccharides from Okra [Abelmoschus esculentus (L.) Moench]: A review | |
Sharma et al. | Moringa (Moringa oleifera Lam.) polysaccharides: Extraction, characterization, bioactivities, and industrial application | |
US20180168198A1 (en) | Nutritional composition | |
Kumari et al. | Onion and garlic polysaccharides: A review on extraction, characterization, bioactivity, and modifications | |
Das et al. | Okra and its various applications in drug delivery, food technology, health care and pharmacological aspects-a review | |
CN115671129A (zh) | 木聚糖在制备预防或治疗骨质疏松的药物或食品中的应用 | |
Yang et al. | Recent developments in Moringa oleifera Lam. polysaccharides: A review of the relationship between extraction methods, structural characteristics and functional activities | |
RU2489934C2 (ru) | Способ производства биологически активных продуктов из бурых водорослей и плодов | |
KR19990073127A (ko) | 건강보조발효식품의제조법 | |
Ojo et al. | Phytochemical, proximate analysis and mineral composition of aqueous crude extract of Ficus asperifolia Miq | |
WO2013162484A1 (fr) | Combinaison d'extrait de fruit de figue (ficus carica) et d'extrait de feuille d'olive (olea europaea) | |
Khomych et al. | The study of biologically active substances of chaenomelesand the products of its processing | |
WO2023078479A1 (fr) | Complément alimentaire | |
EP4426135A1 (fr) | Complément alimentaire | |
Sang et al. | Isolation, structural, biological activity and application of Gleditsia species seeds galactomannans | |
CN104187955B (zh) | 一种玉米花粉保健饮料 | |
CZ35838U1 (cs) | Potravinový doplněk | |
Elsayed et al. | Citrullus lanatus (watermelon) wastes: Maximizing the benefits and saving the environment | |
Kundalia et al. | Nutritional profile, functional characteristics, health benefits, and potential application of edible gum (Gond) | |
Asaduzzaman et al. | Phytochemicals, nutritonal constituents, anti-bacterial and hypoglycemic activity of Aegle marmelos Lin. leaf extract in alloxan induced diabetic rats | |
RU2400107C1 (ru) | Биологически активная добавка к пище | |
RU2385648C1 (ru) | Биологически активная пищевая добавка "баданин" | |
Trivedi et al. | Nutraceutical Potential of Marine Macroalgae |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22809325 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2022809325 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2022809325 Country of ref document: EP Effective date: 20240603 |
|
ENP | Entry into the national phase |
Ref document number: 2022809325 Country of ref document: EP Effective date: 20240603 |